Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: hm who wrote (54)	12/4/2000 3:18:17 PM
From: tuck	Respond to of 1784

CRL gnaws at production costs with mouse cloning partnership. Was thinking production could be enhanced, further swelling margins, by dosing the males with viagra, but saw no mention of this technique. biz.yahoo.com Meanwhile CRL's lock-up expiration approacheth and Trickle nibbles @ 20. Cheers, Tuck

To: hm who wrote (54)	12/6/2000 2:15:52 AM
From: tuck	Respond to of 1784

Squeaking of CRL -- oops, tip of the slongue, there -- here's an article about the murine supply segment of the trickle pie. Hot off the presses! biz.yahoo.com Meanwhile, coming soon to a sustainable rally near you . . . xenogen.com Cheers, Tuck